Valuation: Anupam Rasayan India Ltd

Market Cap 138B 1.44B 1.25B 1.16B 1.07B 2.02B 2.05B 13.75B 5.39B 68.29B 5.41B 5.29B 230B P/E 2026
81.6x
P/E 2027 * 40.9x
Enterprise Value 143B 1.49B 1.3B 1.21B 1.11B 2.09B 2.13B 14.27B 5.59B 70.86B 5.61B 5.49B 238B EV / Sales 2026
6.55x
EV / Sales 2027 * 4.18x
Free-Float
16.06%
Yield 2026
0.12%
Yield 2027 * 0.17%
17/07 Anupam Rasayan India Ltd acquired Mates Visa Consultancy Private Limited for INR 0.01 million. CI
15/07 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
06/07 Tanfac Industries Limited announced that it expects to receive INR 1.734872962 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited CI
12/06 Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry CI
04/06 Crisil Places Anupam Rasayan Ratings on Watch Developing After Bliss GVS Acquisition Announcement MT
25/05 Anupam Rasayan India Ltd, Q4 2026 Earnings Call, May 25, 2026
24/05 Anupam Rasayan India Ltd Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
24/05 Anupam Rasayan India Limited Announces Resignation of Vishal Thakkar as Deputy Chief Financial Officer and Key Managerial Personnel, Effective May 23, 2026 CI
24/05 Anupam Rasayan India Ltd Recommends Final Dividend for the Financial Year 2025-26 CI
23/05 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
23/05 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
23/05 Anupam Rasayan India Ltd entered into a share purchase agreement to acquire 43.30% stake in Bliss GVS Pharma Limited for INR 13.7 billion. CI
28/02 Anupam Rasayan India Ltd completed the acquisition of Jayhawk Fine Chemicals Corporation from CABB Group GmbH. CI
1 day-0.42%
1 week-2.53%
Current month-4.49%
1 month-4.49%
3 months-9.57%
6 months-3.10%
Current year-8.59%
1 week 1,203.5
Extreme 1203.5
1,257
1 month 1,203.5
Extreme 1203.5
1,299.6
Current year 1,162.8
Extreme 1162.8
1,415.4
1 year 1,047.4
Extreme 1047.4
1,415.4
3 years 600.95
Extreme 600.95
1,415.4
5 years 547.1
Extreme 547.1
1,415.4
10 years 472.25
Extreme 472.25
1,415.4
Manager TitleAgeSince
Chief Executive Officer - 11/09/2023
Director of Finance/CFO 36 15/03/2022
Chief Operating Officer 54 23/02/2021
Director TitleAgeSince
Chairman 50 23/04/2013
Director/Board Member 52 01/01/1992
Chairman 77 31/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.42%-2.53% - - 1.44B
-1.71%+2.11%+4.84%+49.84% 78.62B
-1.00%+1.56%-4.84%+10.45% 37.62B
+0.29%+16.14%-6.02%-33.14% 35.77B
-1.54%+4.03%+19.52%+37.21% 28.49B
-0.09%+4.18%+27.94%+13.22% 23.78B
-2.04%-2.41%+82.52%-8.98% 19.55B
-0.90%+0.35%-35.94%-40.67% 18.75B
-3.40%+0.09%+5.86%+64.60% 14.34B
-2.86%+2.44%+11.97%-10.42% 14.47B
Average -1.37%+3.84%+11.76%+9.13% 30.15B
Weighted average by Cap. -1.31%+4.57%+8.84%+15.99%

Financials

2026 2027 *
Net sales 22.24B 233M 202M 188M 173M 326M 332M 2.22B 871M 11.05B 875M 856M 37.14B 37.23B 390M 339M 315M 290M 546M 556M 3.72B 1.46B 18.49B 1.46B 1.43B 62.18B
Net income 1.59B 16.64M 14.46M 13.43M 12.38M 23.32M 23.74M 159M 62.23M 789M 62.5M 61.14M 2.65B 3.37B 35.29M 30.65M 28.46M 26.25M 49.45M 50.34M 337M 132M 1.67B 133M 130M 5.63B
Net Debt 5.16B 54.04M 46.94M 43.59M 40.2M 75.72M 77.09M 516M 202M 2.56B 203M 198M 8.62B 18.21B 191M 166M 154M 142M 267M 272M 1.82B 713M 9.04B 716M 700M 30.41B
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Employees
2,606
Date Price Change Volume
31/07/26 INR 1,206.55 -0.42% 2,059
30/07/26 INR 1,211.65 +0.01% 4,082
29/07/26 INR 1,211.50 -0.65% 4,749
28/07/26 INR 1,219.40 +0.02% 3,980
27/07/26 INR 1,219.15 -2.41% 2,361
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,210.80INR
Average target price
1,143.00INR
Spread / Average Target
-5.60%

Quarterly revenue - Rate of surprise